NCT03106415
- Conditions
- Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Metastatic Triple-Negative Breast Carcinoma
Explore clinical trials studying Metastatic Triple-Negative Breast Carcinoma. Study availability and eligibility vary by location and protocol.
31 public trials
18 recruiting studies
Metastatic Triple-Negative Breast Carcinoma trial results
NCT02971761
- Conditions
- Androgen Receptor Positive, Breast Diseases, Breast Neoplasms, +10 more
- Locations
-
- City of Hope Corona Corona, California, United States
- City of Hope Medical Center Duarte, California, United States
- City of Hope Antelope Valley Lancaster, California, United States
- City of Hope Mission Hills Mission Hills, California, United States
NCT03853707
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic High Grade Fallopian Tube Serous Adenocarcinoma, +27 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
Active, Not Recruiting
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
NCT02498613
- Conditions
- Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +39 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UC San Diego Medical Center - Hillcrest San Diego, California, United States
- UCSF Medical Center-Mount Zion San Francisco, California, United States
Active, Not Recruiting
Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer
NCT04345913
- Conditions
- Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +8 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Smilow Cancer Hospital-Derby Care Center Derby, Connecticut, United States
- Smilow Cancer Hospital Care Center-Fairfield Fairfield, Connecticut, United States
- Smilow Cancer Hospital Care Center at Glastonbury Glastonbury, Connecticut, United States
Active, Not Recruiting
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
NCT04514484
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
- University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
NCT03941730
- Conditions
- Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +9 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- UCSF Medical Center-Mission Bay San Francisco, California, United States
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
Active, Not Recruiting
CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer
NCT05081492
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, Not Recruiting
NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy
NCT03589339
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +47 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Emory University Atlanta, Georgia, United States
- University of Chicago Medical Center Chicago, Illinois, United States